Revance wants you to 'Break Up With Botox' as it goes to war with AbbVie in new anti-wrinkle market battle

AbbVie’s Botox is a major blockbuster and king of the anti-wrinkle aesthetics market, but there are new contenders coming for its crown.

Revance, which markets its rival anti-wrinkle therapy Daxxify, is one of those battling for market share and is pulling no punches in its marketing war against Botox after officially launching its drug this year.